Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification

NCT00124709 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1091

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: Pimecrolimus
DRUG: Corticosteroid

Sponsor

Novartis Pharmaceuticals